Efficacy, safety, and cost of new anticancer drugs

BMJ. 2002 Aug 3;325(7358):269-71. doi: 10.1136/bmj.325.7358.269.
No abstract available

MeSH terms

  • Antineoplastic Agents* / adverse effects
  • Antineoplastic Agents* / economics
  • Antineoplastic Agents* / therapeutic use
  • Drug Approval
  • Drug Costs
  • Europe
  • Humans

Substances

  • Antineoplastic Agents